Stability testing of drug substances and drug products.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 180
- Publication type:
- Article
Works matching IS 10109609 AND DT 1999 AND VI 13 AND IP 3
Results: 34
1
2
Monographs for medicinal plants.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 179
- Publication type:
- Article
3
Measures to combat counterfeit drugs.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 179
- Publication type:
- Article
4
Aristolochia and renal failure.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 174
- Publication type:
- Article
5
Antidotes and other substances used in poisonings.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 175
- Publication type:
- Article
6
Immune globulin intravenous products: risks identified.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 174
- Publication type:
- Article
7
Ticlopidine and haematological reactions.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 174
- Publication type:
- Article
8
Pimozide labelling changes.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 173
- Publication type:
- Article
9
Pioglitazone to treat type 2 diabetes.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 173
- Publication type:
- Article
10
Losartan and irbesartan: adverse reactions.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 173
- Publication type:
- Article
11
Medifoxamine: hepatic injury.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 172
- Publication type:
- Article
12
Alendronate and gastrointestinal disorders.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 173
- Publication type:
- Article
13
Leukotriene receptor antagonists: suspected adverse reactions.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 172
- Publication type:
- Article
14
Flutamide: change in product labelling.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 172
- Publication type:
- Article
15
Over-the-counter emergency contraception approved.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 172
- Publication type:
- Article
16
Olanzapine: warning of neutropenia.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 171
- Publication type:
- Article
17
Southern hemisphere influenza vaccine: 2000.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 171
- Publication type:
- Article
18
Synercid for certain vancomycin-resistant infections.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 171
- Publication type:
- Article
19
Oseltamivir approved for influenza.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 170
- Publication type:
- Article
20
Zanamivir: inhaled treatment for influenza.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 170
- Publication type:
- Article
21
Rotavirus vaccine and intussusception.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 170
- Publication type:
- Article
22
New WHO initiative in vaccine safety.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 169
- Publication type:
- Article
23
DNA vaccines: improvements pending.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 168
- Publication type:
- Article
24
Medical products and the Internet: a guide to finding reliable information.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 163
- Publication type:
- Article
25
International comparator products for bioquivalence testing.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 158
- Publication type:
- Article
26
Guidelines for the treatment of hypertension.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 157
- Publication type:
- Article
27
Importance of fixed-dose combinations in tuberculosis control.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 156
- Publication type:
- Article
28
The growwing importance of drug donations.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 155
- Publication type:
- Article
29
Spironolactone: severe heart failure cut by one-third.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 153
- Publication type:
- Article
30
Nevirapine and vertical transmission of HIV.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 152
- Publication type:
- Article
31
Leishmaniasis: will new technology provide a breakthrough?
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 150
- Publication type:
- Article
32
Drug donations to Albania.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 148
- Publication type:
- Article
33
Emergency situations and controlled medicines.
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 147
- Publication type:
- Article
34
International Nonproprietary Names for Pharmaceutical Substances (INN).
- Published in:
- WHO Drug Information, 1999, v. 13, n. 3, p. 181
- Publication type:
- Article